Alivand M - Search Results

1

Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications.

Moghadasi M, Alivand M, Fardi M, Moghadam KS, Solali S. Moghadasi M, et al. Among authors: alivand m. Pathol Res Pract. 2020 Mar;216(3):152827. doi: 10.1016/j.prp.2020.152827. Epub 2020 Jan 20. Pathol Res Pract. 2020. PMID: 31983567 Review.

2

Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.

Alivand MR, Soheili ZS, Pornour M, Solali S, Sabouni F. Alivand MR, et al. J Cell Biochem. 2017 Oct;118(10):3193-3204. doi: 10.1002/jcb.25965. Epub 2017 Apr 12. J Cell Biochem. 2017. PMID: 28252217

3

Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.

Zare M, Bastami M, Solali S, Alivand MR. Zare M, et al. Among authors: alivand mr. J Cell Physiol. 2018 May;233(5):3729-3744. doi: 10.1002/jcp.26116. Epub 2017 Sep 7. J Cell Physiol. 2018. PMID: 28771724 Review.

4

HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications.

Bayat S, Shekari Khaniani M, Choupani J, Alivand MR, Mansoori Derakhshan S. Bayat S, et al. Among authors: alivand mr. Biomed Pharmacother. 2018 Jan;97:1445-1453. doi: 10.1016/j.biopha.2017.11.065. Epub 2017 Dec 14. Biomed Pharmacother. 2018. PMID: 29156535 Review.

5

Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.

Choupani J, Mansoori Derakhshan S, Bayat S, Alivand MR, Shekari Khaniani M. Choupani J, et al. Among authors: alivand mr. J Cell Physiol. 2018 Jun;233(6):4443-4457. doi: 10.1002/jcp.26302. Epub 2018 Jan 15. J Cell Physiol. 2018. PMID: 29194618 Review.

6

Double sword role of EZH2 in leukemia.

Safaei S, Baradaran B, Hagh MF, Alivand MR, Talebi M, Gharibi T, Solali S. Safaei S, et al. Among authors: alivand mr. Biomed Pharmacother. 2018 Feb;98:626-635. doi: 10.1016/j.biopha.2017.12.059. Epub 2017 Dec 29. Biomed Pharmacother. 2018. PMID: 29289837 Review.

7

Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].

Safaei S, Baradaran B, Hagh MF, Alivand MR, Talebi M, Gharibi T, Solali S. Safaei S, et al. Among authors: alivand mr. Biomed Pharmacother. 2018 May;101:786. doi: 10.1016/j.biopha.2018.02.101. Epub 2018 Mar 22. Biomed Pharmacother. 2018. PMID: 29525673 No abstract available.

8

Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.

Hassanzadeh A, Farshdousti Hagh M, Alivand MR, Akbari AAM, Shams Asenjan K, Saraei R, Solali S. Hassanzadeh A, et al. Among authors: alivand mr. J Cell Physiol. 2018 Oct;233(10):6470-6485. doi: 10.1002/jcp.26585. Epub 2018 May 9. J Cell Physiol. 2018. PMID: 29741767 Review.

9

Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy.

Abtin M, Alivand MR, Khaniani MS, Bastami M, Zaeifizadeh M, Derakhshan SM. Abtin M, et al. Among authors: alivand mr. J Cell Biochem. 2018 Sep;119(9):7151-7165. doi: 10.1002/jcb.26754. Epub 2018 Jun 15. J Cell Biochem. 2018. PMID: 29905007

10

Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells.

Marofi F, Vahedi G, Solali S, Alivand M, Salarinasab S, Zadi Heydarabad M, Farshdousti Hagh M. Marofi F, et al. Among authors: alivand m. J Cell Physiol. 2019 May;234(5):6230-6243. doi: 10.1002/jcp.27352. Epub 2018 Sep 24. J Cell Physiol. 2019. PMID: 30246336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page